Healthcare >> CEO Interviews >> October 17, 2003
LEON O. MOULDER JR. is President and Chief Executive Officer of MGI
PHARMA, INC. He joined MGI PHARMA in September 1999 as Executive Vice
President, was promoted to President and Chief Operating Officer in May
2002 and to his current position as President and Chief Executive
Officer in May 2003. Prior to joining MGI, he was Vice President,
Business Development and Commercial Affairs and was part of the founding
management team of Eligix, Inc., a privately owned biomedical company
focused on developing therapies for cancer, organ transplantation and
autoimmune diseases. This followed 16 years of various sales, marketing,
product and operational management, and business development positions
with Hoechst Marion Roussel (HMR) and its predecessor companies, Marion
Laboratories and Marion Merrell Dow Pharmaceuticals. Mr. Moulder's
tenure at HMR culminated as Product Group Director, Oncology and Anti-
Infectives. He began his career in 1980 at Temple University Hospital as
a clinical pharmacist, responsible for all clinical and operational
pharmacy services provided to the medical research unit and intensive
care units. Mr. Moulder received a Bachelor's degree in Pharmacy from
Temple University and a Master's degree in Business Administration from
the University of Chicago. Profile
Mr. Moulder: MGI PHARMA, INC., is an oncology-focused biopharmaceutical
company that acquires, develops and commercializes proprietary
